Hong-Juan Liu Selected Research

wuzi yanzong

4/2022

Study on the mechanism of Wuzi-Yanzong-Wan-medicated serum interfering with the mitochondrial permeability transition pore in the GC-2 cell induced by atractyloside.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong-Juan Liu Research Topics

Disease

2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2019 - 10/2017
1	Male Infertility (Male Sterility) 04/2022
1	Oligospermia (Oligozoospermia) 12/2021
1	Diarrhea 12/2021
1	Restless Legs Syndrome (Restless Legs) 10/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2018
1	Septic Shock (Toxic Shock Syndrome) 06/2015
1	Sepsis (Septicemia) 06/2015

Drug/Important Bio-Agent (IBA)

2	Therapeutic UsesIBA 01/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2015
1	wuzi yanzongIBA 04/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 12/2021
1	Long Noncoding RNAIBA 01/2021
1	AzolesIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	barbituric acid (barbiturate)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 10/2018
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2015
1	pro-brain natriuretic peptide (1-76)IBA 06/2015
1	C-Reactive ProteinIBA 06/2015
1	Troponin IIBA 06/2015

Therapy/Procedure

1	Therapeutics 01/2022
1	Length of Stay 12/2021